AF
KRRO icon

Amalgamated Financial’s Korro Bio KRRO Stock Holding History

Amalgamated Financial’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$8K Buy
+77
New +$14.7K ﹤0.01% 2928

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Amalgamated Financial's KRRO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Korro Bio (KRRO) in Q1 2022: 77 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #2928 among its holdings.

85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Amalgamated Financial held 77 shares of Korro Bio worth $8K as of Q1 2022.
  • Korro Bio was a new Amalgamated Financial position in Q1 2022.
  • Korro Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2928 holding.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.